Table 1 Selected patient data at time of the first in-center HD treatment
| Â | Â | % |
Patients | 1774 | Â |
Age at start of first in-center HD treatment | 59 ± 16.2 |  |
Gender (male/female) | 944:830 | 53.2:46.8 |
Race (White: Black: Other/Unknown) | Â | 42.7:36.3:21.0 |
Primary disease leading to renal failure | Â | Â |
Glomerulonephritis | 259 | 14.6 |
Hypertension | 427 | 24.1 |
Diabetes mellitus Type I (juvenile) | 71 | 4 |
Diabetes mellitus Type II (adult onset or unspecified) | 577 | 32.4 |
Other | 440 | 24.8 |
Major known co-morbid conditions at study entry | Â | Â |
Arteriosclerotic heart disease | 410 | 23.1 |
Cerebral vascular disease | 148 | 8.3 |
Peripheral vascular disease | 215 | 12.1 |
Malignant disease | 161 | 9.1 |
AIDS | 74 | 4.2 |
Diabetes mellitus Type I (juvenile) | 82 | 4.62 |
Diabetes mellitus Type II (adult onset or unspecified) | 670 | 37.8 |
Peptic ulcer disease | 37 | 2.1 |
Previous kidney transplant | 74 | 4.2 |